Table 1 Baseline, periprocedural, and outcome characteristics of the patients before PSM.
All (n = 337) | Tirofiban group (n = 160) | Non-tirofiban group (n = 177) | P value | |
|---|---|---|---|---|
Demographics | ||||
Age, yr (range) | 60.3 ± 8.7 (27, 82) | 59.4 ± 8.9 (27, 80) | 61.0 ± 8.4 (40, 82) | 0.092 |
Male | 249 (73.9) | 110 (68.8) | 139 (78.5) | 0.041 |
Medical history | ||||
Hypertension | 242 (71.8) | 105 (65.6) | 137 (77.4) | 0.016 |
Diabetes mellitus | 141 (41.8) | 59 (36.9) | 82 (46.3) | 0.079 |
Atrial fibrillation | 4 (1.2) | 2 (1.3) | 2 (1.1) | 1.000 |
Coronary artery disease | 26 (7.7) | 11 (6.9) | 15 (8.5) | 0.583 |
Smoking | 139 (41.2) | 64 (40) | 75 (42.4) | 0.659 |
Family history | 50 (14.8) | 27 (16.9) | 23 (13) | 0.317 |
Stenosis location | 0.012 | |||
Anterior circulation | 161 (47.8) | 88 (55) | 73 (41.2) | – |
Posterior circulation | 176 (52.2) | 72 (45) | 104 (58.8) | – |
Admission NIHSS | 1 (0, 3) | 1 ((0,3) | 1(0,4) | 0.669 |
Interventional parameter | ||||
Stenosis degree before intervention, % | 85 (80,90) | 90 (80,90) | 80 (80,90) | 0.000 |
Stent length, mm | 15 (13,15) | 15 (15,15) | 13 (9,15) | 0.000 |
Stent diameter, mm | 3 (3,3.5) | 3 (3,3.5) | 3 (3,3.5) | 0.139 |
Stenosis degree after intervention, % | 0 (0,0) | 0 (0,0) | 0 (0,0) | 0.286 |
